Data Integrity and Antibiotic Clinical Trials: FDA, Industry Try Systemic Therapy

Antibiotic Early Endpoints: FDA Looking At Patient Observations

FDA Catching Antibiotic Incentive Bug: Agency Primed To Consider Ways To Shorten Route for Resistant-Strain Drugs